Floatz logo

241 assets in Parkinson Disease

Therapeutic assets addressing Parkinson Disease, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Istradefylline
Parkinson Disease
Georgetown UniversityP4BBB (78)
Rasagiline
Parkinson Disease
Guangzhou Henovcom Bioscience Co. Ltd.P4BBB (78)
Opicapone
Parkinson Disease
Bial - Portela C S.A.P4BBB (76)
Carbidopa
Parkinson Disease
Tanta UniversityP4BBB (75)
(18F)-FP-(+)-DTBZ
Parkinson Disease
Michael J. Fox Foundation for Parkinson's ResearchP2/3BBB (74)
Entacapone
Parkinson Disease
University Hospital TuebingenP4BBB (74)
Levodopa
Parkinson Disease
McMaster UniversityP4BBB (74)
Rotigotine
Parkinson Disease
Eva PharmaP4BBB (74)
Amantadine
Parkinson Disease
University Hospital, ToulouseP4BBB (72)
Apomorphinum
Parkinson Disease
Serina TherapeuticsP4BBB (72)
Atomoxetine
Parkinson Disease
Radboud University Medical CenterP4BBB (72)
Abbv-951
Parkinson Disease
AbbVieP3BB (71)
ipx203
Parkinson Disease
The Cleveland ClinicP4BB (69)
Terazosin
Parkinson Disease
Nandakumar NarayananP4BB (68)
Dexmedetomidine
Parkinson Disease
Beijing Tiantan HospitalP4BB (66)
Droxidopa
Parkinson Disease
Loma Linda UniversityP4BB (66)
hrg2010
Parkinson Disease
Jiangsu HengRui Medicine Co., Ltd.P3BB (66)
Methylphenidate
Parkinson Disease
Ralph H. Johnson VA Medical CenterP4BB (66)
Ambroxol
Parkinson Disease
University College, LondonP3BB (65)
Crisugabalin
Parkinson Disease
Guangdong Provincial People's HospitalP4BB (65)
Tavapadon
Parkinson Disease
Cerevel Therapeutics, LLCP3BB (65)
Vortioxetine
Parkinson Disease
Marianna AmboniP4BB (65)
Phenserine
Parkinson Disease
Annovis Bio Inc.P3BB (64)
Propofol
Parkinson Disease
Nyree PennP4BB (64)
Hypoxanthine Riboside
Parkinson Disease
Fujita Health UniversityP3B (63)
nd0612
Parkinson Disease
NeuroDerm Ltd.P3B (63)
Paroxetine
Parkinson Disease
State University of New York at BuffaloP3B (63)
Posiphen
Parkinson Disease
Annovis Bio Inc.P3B (63)
Aav-Gad
Parkinson Disease
MeiraGTx, LLCP2B (61)
Glutathione
Parkinson Disease
Gateway Institute for Brain ResearchP2B (61)
Melatonin
Parkinson Disease
Bangladesh Medical UniversityP4B (61)
Mirabegron
Parkinson Disease
VA Office of Research and DevelopmentP4B (61)
Bemdaneprocel
Parkinson Disease
BlueRock TherapeuticsP3B (60)
Pimavanserin
Parkinson Disease
Joshua Woolley, MD, PhDP4B (60)
Solengepras
Parkinson Disease
CerevanceP3B (60)
Telmisartan
Parkinson Disease
University College, LondonP3B (60)
Varenicline
Parkinson Disease
Vikas KotagalP4B (60)
FDOPA
Parkinson Disease
Andrew NewbergP3B (59)
Lemborexant
Parkinson Disease
YangPanP4B (59)
Prasinezumab
Parkinson Disease
University Hospital TuebingenP3B (59)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone
Parkinson Disease
VA Office of Research and DevelopmentP2B (58)
Dapagliflozin
Parkinson Disease
Mayo ClinicP4B (58)
Kdt-3594
Parkinson Disease
Kissei Pharmaceutical Co., Ltd.P2B (58)
Metformin
Parkinson Disease
Tanta UniversityP3B (58)
Safinamide Mesilate
Parkinson Disease
Eisai Korea Inc.P4B (58)
Sitagliptin
Parkinson Disease
Mayo ClinicP4B (58)
Fludeoxyglucose
Parkinson Disease
Universitaire Ziekenhuizen KU LeuvenP2B (57)
Minzasolmin
Parkinson Disease
UCB Biopharma SRLP2B (57)
Pyridostigmine
Parkinson Disease
University of Vermont Medical CenterP2B (57)
vtx3232
Parkinson Disease
Zomagen Biosciences Ltd.P2B (57)
Showing 1 to 50 of 241 assets
PreviousPage 1 of 5Next